Finance

Lists
AMTM:NYSE
Amentum Holdings Inc
$20.19
0.00%
(0.00) 1D
Sep 17, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AMTM...
Mkt. cap
4.94B
Avg. vol.
2.28M
Volume
834.00
P/E ratio
24.26
52-wk high
$38.11
52-wk low
$19.21
EPS
$0.83
Shares outstanding
244.51M
No. of employees
50K
Mkt. cap
4.94B
Avg. vol.
2.28M
Volume
834.00
P/E ratio
24.26
52-wk high
$38.11
52-wk low
$19.21
EPS
$0.83
Shares outstanding
244.51M
No. of employees
50K
News stories
From web sources and news partners
About Amentum Holdings Inc
CEO-
Employees50K
Founded2023
Headquarters-
SectorService
Websiteamentum.com
Analyst ratings
Based on 9 analysts giving stock ratings to AMTM in the past 3 months
Buy
Buy
3
Hold
6
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for AMTM in the last 3 months.
Highest
Current $20.19
$40.00 (+98.12%)
Average
$28.67 (+42.00%)
Lowest
$23.00 (+13.92%)
Analyst
Recommendation
Action
Price target
Projected
Date
Noah Poponak
Goldman Sachs
Hold
Maintained
$24.00
+18.9%
08/19/2026
Seth Seifman
J.P. Morgan
Hold
Reiterated
$26.00
+28.8%
08/17/2026
Andre Madrid
BTIG
Buy
Maintained
$30.00
+48.6%
08/12/2026
Kenneth Herbert
RBC Capital
Hold
Maintained
$26.00
+28.8%
08/11/2026
Greg Parrish
Morgan Stanley
Hold
Maintained
$24.00
+18.9%
08/12/2026
Colin Canfield
Cantor Fitzgerald
Buy
Maintained
$40.00
+98.1%
08/10/2026
Tobey Sommer
Truist Financial
Buy
Reiterated
$35.00
+73.4%
08/12/2026
Mariana Perez Mora
Bank of America Securities
Hold
Maintained
$30.00
+48.6%
07/20/2026
Gavin Parsons
UBS
Hold
Reiterated
$23.00
+13.9%
06/29/2026
Matthew Akers
Exane BNP Paribas
Sell
Initiated
$22.00
+9%
05/26/2026
Kristine Liwag
Morgan Stanley
Hold
Maintained
$35.00
+73.4%
02/11/2026
Last report
Aug 11, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$0.67 / $0.61
+9.65%beat
Revenue / Est. (USD)
3.49B / 3.57B
-2.30%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
3.92B
3.24B
3.48B
3.49B
Cost of goods sold
3.47B
2.91B
3.13B
3.13B
Cost of revenue
3.47B
2.91B
3.13B
3.13B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187.00M
115.00M
108.00M
113.00M
Operating expense
308.00M
209.00M
202.00M
207.00M
Total operating expenses
3.78B
3.12B
3.34B
3.34B
Operating income
143.00M
117.00M
143.00M
153.00M
Other non operating income
-
-
-
-
EBT including unusual items
34.00M
64.00M
78.00M
94.00M
EBT excluding unusual items
66.00M
64.00M
94.00M
119.00M
Income tax expense
-3.00M
20.00M
24.00M
28.00M
Effective tax rate
-8.82%
31.25%
30.77%
29.79%
Other operating expenses
-
-
-
-
Net income
40.00M
44.00M
54.00M
66.00M
Net profit margin
1.02%
1.36%
1.55%
1.89%
Earnings per share
0.63
0.54
0.61
0.67
Interest and investment income
-
-
-
-
Interest expense
-92.00M
-74.00M
-73.00M
-62.00M
Net interest expenses
-92.00M
-74.00M
-73.00M
-62.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
275.00M
223.00M
243.00M
254.00M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps